7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
      
    		                           
      cash flows from operating activities
    		                           
      net income including non-controlling interests
    		6,652,000,000 1,350,000,000 1,774,000,000 6,901,000,000 2,599,000,000 1,008,000,000 -663,000,000 1,700,000,000 219,000,000 394,000,000 -157,000,000 600,000,000 -1,204,000,000 -2,616,000,000 -5,918,000,000 879,000,000 -2,439,000,000 1,112,000,000 -122,000,000 -962,000,000 -1,108,000,000 -1,772,000,000 -2,946,000,000 -1,091,000,000    
      adjustments to reconcile net income to net cash from operating activities:
    		                           
      depreciation and amortization
    		195,000,000 181,000,000 178,000,000 176,000,000 186,000,000 181,000,000 194,000,000 203,000,000 205,000,000 208,000,000 207,000,000 223,000,000 227,000,000 243,000,000 254,000,000 246,000,000 218,000,000 226,000,000 212,000,000 180,000,000 138,000,000 129,000,000 128,000,000 101,000,000 102,000,000 123,000,000 146,000,000 
      stock-based compensation
    		465,000,000 475,000,000 435,000,000 419,000,000 438,000,000 455,000,000 484,000,000 469,000,000 492,000,000 504,000,000 470,000,000 482,000,000 482,000,000 470,000,000 359,000,000 334,000,000 281,000,000 272,000,000 281,000,000 236,000,000 183,000,000 131,000,000 277,000,000 243,000,000 401,000,000 3,941,000,000 11,000,000 
      deferred income taxes
    		-4,167,000,000 87,000,000 -412,000,000 -6,128,000,000 124,000,000 -7,000,000 -16,000,000 -6,000,000 16,000,000 6,000,000 10,000,000 -190,000,000 16,000,000 14,000,000 -281,000,000 -210,000,000 -115,000,000 -487,000,000 120,000,000 6,000,000 10,000,000       
      unrealized gain on debt and equity securities
    		  -51,000,000                         
      unrealized foreign currency transactions
    		22,000,000 -101,000,000 -51,000,000 135,000,000 -36,000,000 59,000,000 150,000,000 -18,000,000 71,000,000 2,000,000 83,000,000 71,000,000 15,000,000 25,000,000 -15,000,000 26,000,000 14,000,000 -15,000,000 13,000,000 4,000,000 31,000,000 6,000,000 7,000,000 32,000,000 -11,000,000 -1,000,000 -4,000,000 
      other
    		-16,000,000 106,000,000 -27,000,000 257,000,000 -31,000,000 -79,000,000 -59,000,000 -23,000,000 -35,000,000 6,000,000 4,000,000 -12,000,000 7,000,000 -7,000,000 5,000,000 -46,000,000 -12,000,000 -3,000,000 65,000,000 -4,000,000 -34,000,000 5,000,000 -10,000,000 5,000,000 19,000,000 0 -1,000,000 
      change in assets and liabilities, net of impact of business acquisitions and disposals:
    		                           
      accounts receivable
    		-22,000,000 -212,000,000 -123,000,000 246,000,000 196,000,000 -162,000,000 -422,000,000 -395,000,000 -518,000,000 -13,000,000 168,000,000 -323,000,000 -90,000,000 -103,000,000 -26,000,000 -243,000,000 -205,000,000 -114,000,000 -35,000,000 -238,000,000 -137,000,000 73,000,000 444,000,000 -65,000,000 94,000,000 -226,000,000 -210,000,000 
      prepaid expenses and other assets
    		-126,000,000 -251,000,000 -497,000,000 -30,000,000 -234,000,000 -108,000,000 -322,000,000 -281,000,000 -948,000,000 -114,000,000 -119,000,000 -139,000,000 -115,000,000 78,000,000 -20,000,000 -7,000,000 -220,000,000 58,000,000 -67,000,000 -65,000,000 18,000,000 112,000,000 29,000,000 -11,000,000 -289,000,000 -103,000,000 -75,000,000 
      operating lease right-of-use assets
    		46,000,000 46,000,000 43,000,000 59,000,000 44,000,000 47,000,000 46,000,000 50,000,000 47,000,000 42,000,000 52,000,000 51,000,000 47,000,000 53,000,000 42,000,000 49,000,000 39,000,000 39,000,000 38,000,000 67,000,000 137,000,000 80,000,000 57,000,000 66,000,000    
      accounts payable
    		101,000,000 125,000,000 6,000,000 62,000,000 48,000,000 -70,000,000 46,000,000 -22,000,000 112,000,000 -19,000,000 -7,000,000 -53,000,000 -35,000,000 -53,000,000 8,000,000 19,000,000 -114,000,000 188,000,000 -3,000,000 -99,000,000 -24,000,000 36,000,000 -46,000,000 118,000,000 -32,000,000   
      accrued insurance reserves
    		592,000,000 812,000,000 675,000,000 658,000,000 776,000,000 692,000,000 693,000,000 576,000,000 501,000,000 588,000,000 350,000,000 251,000,000 159,000,000 192,000,000 134,000,000 26,000,000 469,000,000 48,000,000 -27,000,000 13,000,000 -8,000,000 -85,000,000 77,000,000     
      accrued expenses and other liabilities
    		111,000,000 -20,000,000 430,000,000 -158,000,000 -243,000,000 141,000,000 590,000,000 -216,000,000 740,000,000 -87,000,000 -142,000,000 -405,000,000 483,000,000 486,000,000 -72,000,000 177,000,000 129,000,000 206,000,000 556,000,000 6,000,000 414,000,000 -17,000,000 -320,000,000 -37,000,000 -143,000,000 796,000,000 344,000,000 
      operating lease liabilities
    		-54,000,000 -51,000,000 -56,000,000 -64,000,000 -76,000,000 -25,000,000 -56,000,000 -43,000,000 -47,000,000 -46,000,000 -44,000,000 -46,000,000 -81,000,000 -49,000,000 -39,000,000 -60,000,000 -54,000,000 -20,000,000 -50,000,000 -27,000,000 -62,000,000 7,000,000 -49,000,000 -59,000,000    
      net cash from operating activities
    		2,328,000,000 2,564,000,000 2,324,000,000 1,750,000,000 2,151,000,000 1,820,000,000 1,416,000,000 823,000,000 966,000,000 1,190,000,000 606,000,000 -244,000,000 432,000,000 439,000,000 15,000,000 -107,000,000 614,000,000 -341,000,000 -611,000,000 -805,000,000 -406,000,000 -1,071,000,000 -463,000,000 -1,799,000,000 -878,000,000 -922,000,000 -722,000,000 
      capex
    		-98,000,000 -89,000,000 -74,000,000 -44,000,000 -42,000,000 -99,000,000 -57,000,000 -55,000,000 -61,000,000 -50,000,000 -57,000,000 -59,000,000 -74,000,000 -57,000,000 -62,000,000 -80,000,000 -90,000,000 -57,000,000 -71,000,000 -123,000,000 -131,000,000 -164,000,000 -198,000,000 -143,000,000 -121,000,000 -148,000,000 -129,000,000 
      free cash flows
    		2,230,000,000 2,475,000,000 2,250,000,000 1,706,000,000 2,109,000,000 1,721,000,000 1,359,000,000 768,000,000 905,000,000 1,140,000,000 549,000,000 -303,000,000 358,000,000 382,000,000 -47,000,000 -187,000,000 524,000,000 -398,000,000 -682,000,000 -928,000,000 -537,000,000 -1,235,000,000 -661,000,000 -1,942,000,000 -999,000,000 -1,070,000,000 -851,000,000 
      cash flows from investing activities
    		                           
      purchases of property and equipment
    		-98,000,000 -89,000,000 -74,000,000 -44,000,000 -42,000,000 -99,000,000 -57,000,000 -55,000,000 -61,000,000 -50,000,000 -57,000,000 -59,000,000 -74,000,000 -57,000,000 -62,000,000 -80,000,000 -90,000,000 -57,000,000 -71,000,000 -123,000,000 -131,000,000 -164,000,000 -198,000,000     
      purchases of non-marketable equity securities
    		-95,000,000 -12,000,000 -179,000,000 -1,000,000 -56,000,000 -58,000,000 -174,000,000 -10,000,000    0 0 -1,000,000 -13,000,000 -125,000,000 0 -54,000,000 -803,000,000         
      purchases of marketable securities
    		-6,310,000,000 -5,095,000,000 -2,540,000,000 -3,020,000,000 -4,428,000,000 -3,288,000,000 -2,029,000,000 -2,844,000,000 -3,723,000,000 -1,361,000,000 -846,000,000     0 -587,000,000 -190,000,000 -336,000,000 -608,000,000 -481,000,000 -519,000,000 -493,000,000     
      proceeds from maturities and sales of marketable securities
    		6,514,000,000 4,636,000,000 2,397,000,000 4,437,000,000 1,916,000,000 1,821,000,000 2,030,000,000 2,076,000,000 1,366,000,000 1,127,000,000 500,000,000 0    0 1,148,000,000 447,000,000 696,000,000 559,000,000 379,000,000 322,000,000 100,000,000     
      acquisition of businesses, net of cash acquired
    		0           0 0 0 -59,000,000 -2,203,000,000 -31,000,000 -52,000,000 -28,000,000 65,000,000    0 0   
      other investing activities
    		42,000,000 -97,000,000 -146,000,000 61,000,000 -82,000,000 -60,000,000 -21,000,000 14,000,000 26,000,000 -11,000,000 4,000,000 -2,000,000 -7,000,000 4,000,000 -1,000,000 -5,000,000 0 9,000,000 8,000,000 14,000,000 57,000,000 -10,000,000 -1,000,000     
      net cash from investing activities
    		53,000,000 -1,461,000,000 -542,000,000 1,433,000,000 -2,692,000,000 -1,676,000,000 -242,000,000 -819,000,000 -2,416,000,000 408,000,000 -399,000,000 -1,769,000,000 321,000,000 -54,000,000 -135,000,000 -2,268,000,000 1,216,000,000 101,000,000 -250,000,000 -192,000,000 -365,000,000 -456,000,000 -1,856,000,000 -711,000,000 -129,000,000 -154,000,000 204,000,000 
      cash flows from financing activities
    		                           
      issuance of term loan and notes, net of issuance costs
    		2,232,000,000                           
      principal repayment on term loan and notes
    		   -2,000,000,000 -1,973,000,000 -7,000,000 -6,000,000 -1,525,000,000 -6,000,000 -7,000,000 -1,137,000,000                 
      principal payments on finance leases
    		-37,000,000 -28,000,000 -47,000,000 -50,000,000 -45,000,000 -35,000,000 -42,000,000 -53,000,000 -36,000,000 -42,000,000 -40,000,000 -37,000,000 -39,000,000 -46,000,000 -62,000,000 -60,000,000 -58,000,000 -61,000,000 -47,000,000  -56,000,000 -59,000,000 -60,000,000     
      proceeds from the issuance of common stock under the employee stock purchase plan
    		0   53,000,000 0   45,000,000 0   33,000,000 0   40,000,000 0   43,000,000 0       
      repurchases of common stock
    		-1,463,000,000 -1,363,000,000 -1,785,000,000 -555,000,000 -372,000,000                       
      other financing activities
    		-70,000,000 -51,000,000 -30,000,000 6,000,000 19,000,000 73,000,000 -52,000,000 17,000,000 -9,000,000 6,000,000 -51,000,000 -5,000,000 -4,000,000 -8,000,000 -51,000,000 51,000,000 5,000,000 30,000,000 15,000,000 48,000,000 -1,000,000 -6,000,000 -3,000,000     
      net cash from financing activities
    		-538,000,000 -195,000,000 -1,862,000,000 -3,397,000,000 1,601,000,000 -191,000,000 -100,000,000 46,000,000 -76,000,000 42,000,000 -107,000,000 -89,000,000 212,000,000 5,000,000 -113,000,000 414,000,000 1,556,000,000 36,000,000 -226,000,000 896,000,000 428,000,000 118,000,000 -63,000,000 -83,000,000 1,993,000,000 7,075,000,000 -46,000,000 
      effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents
    		-27,000,000 159,000,000 70,000,000 -179,000,000 62,000,000 -56,000,000 -94,000,000 89,000,000 -69,000,000 27,000,000 16,000,000 145,000,000 -195,000,000 -118,000,000 20,000,000 -24,000,000 -50,000,000 51,000,000 -46,000,000 75,000,000 8,000,000 -19,000,000 -156,000,000 19,000,000 -35,000,000 9,000,000 3,000,000 
      net increase in cash and cash equivalents, and restricted cash and cash equivalents
    		1,816,000,000 1,067,000,000 -10,000,000 -393,000,000 1,122,000,000 -103,000,000 980,000,000 139,000,000   116,000,000 -1,957,000,000 770,000,000   -1,985,000,000    -26,000,000 -335,000,000   -2,574,000,000 951,000,000 6,008,000,000 -561,000,000 
      cash and cash equivalents, and restricted cash and cash equivalents
    		                           
      beginning of period
    		0 0 8,610,000,000    7,004,000,000 0   6,677,000,000 0 0   0 0   0 0 0 12,067,000,000 0 0 0 8,209,000,000 
      end of period
    		1,816,000,000 1,067,000,000 8,600,000,000    7,984,000,000      770,000,000    3,336,000,000           
      reconciliation of cash and cash equivalents, and restricted cash and cash equivalents to the condensed consolidated balance sheets
    		                           
      unrealized (gain) loss on debt and equity securities
    		     -333,000,000 721,000,000 -1,000,000,000 96,000,000 -386,000,000 -320,000,000   1,677,000,000 5,570,000,000   -1,912,000,000 -63,000,000 2,000,000 7,000,000 2,000,000 114,000,000     
      cash and cash equivalents
    		  5,132,000,000          468,000,000    2,039,000,000    -600,000,000 -1,411,000,000 8,165,000,000  906,000,000 5,999,000,000 5,745,000,000 
      restricted cash and cash equivalents-current
    		  1,253,000,000          67,000,000    90,000,000    95,000,000 -70,000,000 193,000,000  -104,000,000 1,000,000 136,000,000 
      bad debt expense
    		   14,000,000 12,000,000 9,000,000 26,000,000 29,000,000 19,000,000 24,000,000 20,000,000 38,000,000 25,000,000 33,000,000 18,000,000 34,000,000 26,000,000 26,000,000 23,000,000 25,000,000 19,000,000 10,000,000 22,000,000 13,000,000 12,000,000 20,000,000 47,000,000 
      income from sale of investments
    		                           
      gain on business divestitures
    		           0    0 0 0 -1,684,000,000 -77,000,000 0       
      accretion of discounts on marketable debt securities
    		                           
      impairments of goodwill, long-lived assets and other assets
    		       9,000,000 -1,000,000 11,000,000 67,000,000 13,000,000 0 2,000,000 13,000,000 100,000,000 0 0 16,000,000 32,000,000 75,000,000 104,000,000 193,000,000     
      impairment of equity method investment
    		           0 0 0 182,000,000             
      loss (income) from equity method investments
    		   10,000,000 12,000,000 12,000,000 4,000,000     -42,000,000 -30,000,000 -17,000,000 -18,000,000             
      revaluation of mlu b.v. call option
    		           -11,000,000 -10,000,000 11,000,000 -181,000,000             
      proceeds from sale of equity method investments
    		                           
      proceeds from business divestiture
    		                           
      proceeds from issuance and sale of subsidiary stock units
    		           0                
      purchase of capped calls
    		                           
      principal repayment on careem notes
    		               -112,000,000 -1,000,000 0 -194,000,000 0 0       
      uber technologies, inc.
    		                           
      consolidated statements of cash flows
    		                           
      redemption of non-controlling interests
    		                           
      supplemental disclosures of cash flow information
    		                           
      cash paid for:
    		                           
      interest, net of amount capitalized
    		       160,000,000    123,000,000 137,000,000   130,000,000 103,000,000   116,000,000 85,000,000 120,000,000 91,000,000 119,000,000 47,000,000 124,000,000 42,000,000 
      income taxes, net of refunds
    		       64,000,000    26,000,000 44,000,000   16,000,000 20,000,000   14,000,000 10,000,000 22,000,000 36,000,000 28,000,000 25,000,000 46,000,000 34,000,000 
      non-cash investing and financing activities:
    		                           
      finance lease obligations
    		       13,000,000    173,000,000 95,000,000   69,000,000 32,000,000    59,000,000       
      right-of-use assets obtained in exchange for lease obligations
    		       37,000,000    101,000,000 -17,000,000               
      ownership interest received in exchange for divestitures
    		               0            
      income from sale of investment
    		        0                   
      proceeds from sale of equity method investment
    		    0 8,000,000 9,000,000  18,000,000                   
      issuance of term loans and notes, net of issuance costs
    		        0 0 1,121,000,000                 
      principal repayments on careem notes
    		                           
      collateral held by insurer
    		               0 724,000,000 28,000,000 108,000,000 80,000,000 81,000,000 86,000,000 92,000,000     
      proceeds from sale of non-marketable equity securities
    		               0 0 0 500,000,000         
      purchase of notes receivables
    		                           
      reclassification from (to) assets held for sale during the period
    		                         0 34,000,000 
      end of period, excluding cash classified within assets held for sale
    		                   -375,000,000 -335,000,000 -1,428,000,000 9,529,000,000 -2,574,000,000 951,000,000 6,008,000,000 7,682,000,000 
      common stock issued in connection with acquisitions
    		               901,000,000    3,802,000,000        
      conversion of convertible notes to common stock related to careem
    		                           
      income from equity method investments
    		        -3,000,000 -4,000,000 -36,000,000     9,000,000 13,000,000 7,000,000 8,000,000 7,000,000 8,000,000       
      restricted cash and cash equivalents-non-current
    		            235,000,000    1,207,000,000    170,000,000 53,000,000 1,171,000,000  149,000,000 8,000,000 1,801,000,000 
      total cash and cash equivalents, and restricted cash and cash equivalents
    		            770,000,000    3,336,000,000    -335,000,000 -1,428,000,000 9,529,000,000  951,000,000 6,008,000,000 7,682,000,000 
      gain from sale of investments
    		               -242,000,000            
      impairment of debt and equity securities
    		                   0 -160,000,000 -13,000,000 1,863,000,000     
      proceeds from sale of equity method investments and grant of related call option
    		                           
      proceeds from business divestiture, net of cash divested
    		                           
      return of capital from equity method investee
    		                   0 0 0 91,000,000     
      issuance of careem notes including the holdback amount
    		                           
      unrealized loss on debt and equity securities
    		                           
      purchase of notes receivable
    		                           
      issuance of senior notes, net of issuance costs
    		                    500,000,000       
      reclassification from assets held for sale during the period
    		                0           
      ownership interest received in exchange for divestiture
    		                           
      conversion of convertible notes to common stock
    		                0           
      gain on business divestiture
    		                      -154,000,000     
      gain on extinguishment of convertible notes and settlement of derivatives
    		                       0    
      proceeds from business disposal, net of cash divested
    		                       0 0 0 293,000,000 
      proceeds from issuance of common stock upon initial public offering, net of offering costs
    		                       0 -4,000,000   
      taxes paid related to net share settlement of equity awards
    		                   -2,000,000    -59,000,000 -146,000,000   
      proceeds from issuance of common stock related to private placement
    		                        0   
      proceeds from issuance and sale of subsidiary preferred stock units
    		                           
      conversion of redeemable convertible preferred stock to common stock upon initial public offering
    		                       0 0   
      conversion of convertible notes to common stock upon initial public offering
    		                       0 0   
      proceeds from sale of subsidiary preferred stock units
    		                           
      purchase of note receivable
    		                 -2,000,000 -216,000,000  0       
      net decrease in cash and cash equivalents, and restricted cash and cash equivalents
    		                      -2,538,000,000     
      ownership interest received in exchange for the divestitures
    		                           
      revaluation of derivative liabilities
    		                       0 0 117,000,000 -175,000,000 
      accretion of discount on long-term debt
    		                   9,000,000 6,000,000 10,000,000 20,000,000 2,000,000 2,000,000 25,000,000 53,000,000 
      payment-in-kind interest
    		                       0 0 4,000,000 6,000,000 
      gain on forfeiture of unvested warrants and related share repurchases
    		                           
      proceeds from sale and disposal of property and equipment
    		                   1,000,000 1,000,000 0 1,000,000     
      purchases of equity method investments
    		                           
      proceeds from issuance of subsidiary preferred stock units
    		                       0    
      principal repayment on revolving lines of credit
    		                           
      principal payments on capital and finance leases
    		                       -18,000,000 -48,000,000   
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    		                           
      repurchase of stock subject to put options related to yandex
    		                           
      financed construction projects
    		                           
      capital and finance lease obligations
    		                       55,000,000 46,000,000   
      settlement of litigation through issuance of redeemable convertible preferred stock
    		                           
      ownership interest in mlu b.v. received in connection with the disposition of uber russia/cis operations
    		                           
      grab debt security received in exchange for the sale of southeast asia operations
    		                           
      ownership interest in zomato received in exchange for the divestiture of uber eats india operations
    		                   0 0 0 171,000,000     
      issuance of unsecured convertible notes in connection with careem acquisition
    		                           
      holdback amount of unsecured convertible notes in connection with careem acquisition
    		                   -331,000,000 0 0 754,000,000     
      purchase of non-marketable equity securities
    		                    0 0 -10,000,000     
      issuance of initial unsecured convertible notes in connection with careem acquisition
    		                    0 0 880,000,000     
      change in assets and liabilities, net of impact of business acquisition and disposals:
    		                           
      proceeds from business disposals, net of cash divested
    		                           
      acquisition of business, net of cash acquired
    		                     0 -1,346,000,000     
      deferred income tax
    		                      -273,000,000 -33,000,000 -24,000,000 -35,000,000 4,000,000 
      income from equity method investment
    		                      12,000,000 9,000,000 9,000,000 10,000,000 6,000,000 
      loss on disposal of property and equipment
    		                       -4,000,000 1,000,000 3,000,000 10,000,000 
      impairment of long-lived assets held for sale
    		                           
      gain on debt and equity securities
    		                       -1,000,000 13,000,000 2,000,000 -16,000,000 
      non-cash deferred revenue
    		                       -13,000,000 -13,000,000 -13,000,000 -13,000,000 
      proceeds from insurance reimbursement, sale and disposal of property and equipment
    		                       10,000,000 0 1,000,000 40,000,000 
      purchase of property and equipment
    		                       -182,000,000 -129,000,000 -148,000,000 -129,000,000 
      purchase of intangible assets
    		                           
      purchase of equity method investments
    		                           
      purchase of non-marketable debt securities
    		                           
      purchase of non-marketable investments
    		                           
      proceeds from issuance of common stock in private placement
    		                           
      proceeds from exercise of stock options, net of repurchases
    		                       14,000,000 0 3,000,000 2,000,000 
      repurchase of outstanding shares
    		                           
      issuance of term loan and senior notes, net of issuance costs
    		                       0    
      principal repayment on term loan
    		                       -7,000,000 -7,000,000 -6,000,000 -7,000,000 
      proceeds from revolving lines of credit
    		                           
      dissolution of joint venture and subsequent proceeds
    		                           
      stock-based compensation capitalized as software development costs
    		                           
      changes in purchases of property, equipment and software recorded in accounts payable and accrued liabilities
    		                       39,000,000 8,000,000   
      changes in share repurchase commitment made in each period
    		                           
      deferred unpaid offering costs
    		                           
      impairment on long-lived assets held for sale
    		                           
      change in operating assets and liabilities, net of impact of business acquisitions and disposals:
    		                           
      accrued insurance reserve
    		                        99,000,000 96,000,000 161,000,000 
      investments in debt securities
    		                           
      net income including redeemable non-controlling interest
    		                         -5,246,000,000 -1,016,000,000 
      gain on extinguishment of convertible notes and settlement of derivative
    		                           
      gain on extinguishment of warrant and call option
    		                           
      changes in operating assets and liabilities:
    		                           
      principal payments on capital leases
    		                          -41,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.